Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register- based prospective cohort study in Norway and Sweden from 2015 to 2017

15 In the temperate language of the UN mission in Afghanistan (UNAMA), the operations of NDS Special Forces, like those of the Khost Protection Force, “appear to be coordinated

Patients with no follow-up data (n = 364) or no change at follow-up (n = 26) has no vertical line. Figure 2 also shows that the majority of patients have a lower index value than

As OAT pa- tients are getting older, somatic causes of death will likely increase [14], although high drug-induced mortal- ity, irrespective of gender, has been found among

Aims To present the substances and their concentrations detected postmortem in patients receiving opioid agonist treat- ment (OAT) strati fi ed by cause of death, estimate the

Methods: We studied pregnancies from 2006 to 2016 within linked population- based registers for births and dispensed prescription drugs from Denmark, Finland, Iceland, Norway,

The first aim was to study the treatment uptake of chronic hepatitis C (HCV) among people enrolled in opioid agonist therapy (OAT), secondly to assess symptoms of mental

The proportion of patients who received ADHD medi- cation increased in the inclusion period. Nevertheless, the dispensation rates were still in the lower range of what was expected.

In the period 2013 to 2017, a steady proportion of the Norwegian OAT population received at least one pre- scription of a benzodiazepine or z-hypnotic. Further- more, the number